Nel ASA's Liquidity Lifeline Faces a Crucial Revenue Test

Nel faces investor pressure as surging orders fail to boost revenue. The Q1 2026 report is critical for proving its costly tech pivot can deliver profits.

Investor patience is wearing thin at Norwegian hydrogen specialist Nel ASA. The company heads into its first-quarter 2026 report on April 22nd carrying a significant order backlog but a persistent inability to convert those contracts into meaningful revenue. This gap between promise and delivery defines the high-stakes moment for the firm.

The numbers from late 2025 paint a stark picture. While the fourth quarter saw a staggering 364% surge in order intake to NOK 686 million, primarily in the PEM division, revenue from customer contracts simultaneously collapsed by 20% to NOK 330 million. For the full year 2025, revenue fell 31%, culminating in a net loss of NOK 1.27 billion. Management has pointed to irregular delivery schedules for large-scale projects as a key reason for this disconnect.

Market sentiment reflects deep skepticism. Analysts at Citigroup recently trimmed their price target from NOK 2.70 to NOK 2.40, maintaining a neutral stance. Berenberg followed suit, cutting its target to NOK 2.30. Analyst James Carmichael cited unpredictable revenue realization and the unproven market readiness of Nel's new technology platform as primary concerns. The consensus price target sits at NOK 2.14, with no analysts currently recommending a buy. Seven experts advise selling the stock.

At the heart of Nel's strategy is a costly technological pivot. The company plans the commercial launch of its "Next Generation Pressurized Alkaline" electrolyzer system in the first half of 2026. This platform promises to be up to 60% cheaper to manufacture. Its development is supported by EU grants covering approximately 60% of eligible costs, with larger deliveries slated for 2027. The initial production capacity carries an estimated price tag of NOK 300 million before subsidies.

This forward-looking bet is shadowed by legacy issues. At its Herøya facility, two idled 500-megawatt production lines for atmospheric alkaline electrolyzers are under review. A decision on their reactivation, sale, or permanent closure is pending, raising the specter of a substantial asset impairment that could further strain the balance sheet.

Despite these challenges, Nel is not without resources. The company holds a liquidity reserve of roughly NOK 1.6 billion, earmarked in part for the new platform's rollout. A strategic partnership provides additional backing; since March 2025, South Korean plant builder Samsung E&A has held a stake of just over 9% in Nel, with Gyuyeon Kang confirmed on the supervisory board.

Recent trading activity shows flickers of optimism. The share price currently stands at around €0.21, having gained over 9% in the past week to break back above its 50-day line at €0.19. Year-to-date, the stock is up approximately 7%, though it remains 16% below its 52-week high.

The upcoming report is a critical juncture. The market demands clear evidence that the late-2025 order boom is finally translating into recognized sales. Investors also await clarity on potential write-downs for the idled Herøya lines. With the next operational milestone—the half-year figures on July 15th—looming shortly after, the pressure on Nel's management to deliver measurable financial progress has never been greater.